PA

Priya Ajit Singh

Director Director DIN 01673440
DIN 01673440 First appointment Oct 2007 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2007
Shareholding value Locked Premium profile

About Priya Ajit Singh

Data last updated:

Priya Ajit Singh has 19 years in corporate governance. Formerly with 1 company, such as Rajasthan Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01673440
Primary Designation Director
First Appointment 01 Oct 2007
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director01 Oct 20071978Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rajasthan Drugs And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Priya Ajit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Ajit Singh

Priya Ajit Singh has 19 years in corporate governance. Formerly with 1 company, such as Rajasthan Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Priya Ajit Singh is associated with 0 companies as a director.

Priya Ajit Singh has expertise in General Business.

Priya Ajit Singh has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available